Literature DB >> 19776690

The role of "metabolic memory" in the natural history of diabetes mellitus.

Józef Drzewoski1, Jacek Kasznicki, Zygmunt Trojanowski.   

Abstract

There is growing evidence that early, intensive treatment of new-onset diabetes mellitus aimed at tight glucose control reduces the risk of micro- and macrovascular complications. Metabolic memory is a term used to describe beneficial effects of immediate intensive treatment of hyperglycemia and the observation that they are maintained for many years, regardless of glycemia in the later course of diabetes. This phenomenon was first observed in preclinical studies and was later confirmed in large clinical trials. It has been suggested that early glycemia normalization can halt hyperglycemia-induced pathological processes associated with enhanced oxidative stress and glycation of cellular proteins and lipids. The phenomenon of metabolic memory suggests that antioxidants and agents degrading advanced glycation end products in addition to strict hypoglycemic treatment can be used to prevent chronic diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776690

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  16 in total

Review 1.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

2.  Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction.

Authors:  Kulbhushan Tikoo; Ekta Sharma; Venkateswara Rao Amara; Himani Pamulapati; Vaibhav Shrirang Dhawale
Journal:  J Biol Chem       Date:  2016-08-22       Impact factor: 5.157

Review 3.  Diabetic retinal neurodegeneration as a form of diabetic retinopathy.

Authors:  Deepak Soni; Pradeep Sagar; Brijesh Takkar
Journal:  Int Ophthalmol       Date:  2021-05-06       Impact factor: 2.031

Review 4.  Role of endothelin receptor A and NADPH oxidase in vascular abnormalities.

Authors:  De-Zai Dai; Yin Dai
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

Review 5.  Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications.

Authors:  Poojitha Rajasekar; Christina L O'Neill; Lydia Eeles; Alan W Stitt; Reinhold J Medina
Journal:  J Diabetes Res       Date:  2015-05-28       Impact factor: 4.011

6.  Corneal nerve fiber pathology in Japanese type 1 diabetic patients and its correlation with antecedent glycemic control and blood pressure.

Authors:  Fukashi Ishibashi; Mika Okino; Marina Ishibashi; Asami Kawasaki; Naoko Endo; Aiko Kosaka; Harumi Uetake
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

Review 7.  Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials.

Authors:  Markolf Hanefeld; Louis Monnier; Oliver Schnell; David Owens
Journal:  Diabetes Ther       Date:  2016-02-10       Impact factor: 2.945

8.  Glucagon-like peptide-1 triggers protective pathways in pancreatic beta-cells exposed to glycated serum.

Authors:  Alessandra Puddu; Roberta Sanguineti; Arianna Durante; Alessio Nencioni; François Mach; Fabrizio Montecucco; Giorgio L Viviani
Journal:  Mediators Inflamm       Date:  2013-04-29       Impact factor: 4.711

9.  Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15.

Authors:  Alessandra Puddu; Roberta Sanguineti; Fabrizio Montecucco; Giorgio Luciano Viviani
Journal:  J Diabetes Res       Date:  2015-06-29       Impact factor: 4.011

10.  Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose.

Authors:  Alessandra Puddu; Roberta Sanguineti; Fabrizio Montecucco; Giorgio L Viviani
Journal:  Mediators Inflamm       Date:  2014-02-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.